Did you know that flu viruses change every year? That’s why yearly vaccination is the most effective way to help prevent flu and its complications.
Are you living with major depressive disorder (MDD)? Are you experiencing persistent sadness, hopelessness, irritability, restlessness, guilt or worthlessness? Indago is collaborating with Axsome Therapeutics on a research study to assess the safety of solriamfetol in adults with depression (SOL-MDD-301 or PARADIGM).
C. diff is a leading cause of infectious diarrhea in adults 65 and older that can result in severe illness and recurrent symptoms. Learn about Pfizer’s new vaccine study which may help to protect against C. diff infection.
This clinical trial’s purpose is to test a new study drug, called AZD0780. The study drug is a small molecule PCSK9 inhibitor that aims to lower the levels of “bad cholesterol” in the blood.
Volunteers who join the trial will take AZD0780(study drug) orally, every day for 12 weeks, which is about three months. Your participation in the study will help to determine the
effectiveness, safety, and tolerability of AZD0780(study drug) and how it affects LDL-C (bad cholesterol) levels and levels of other types of fat in your blood.
You may qualify if you:
- Are male or female of non-childbearing potential within an age range from 18 to 75 years.
- Fasting LDL-C levels (bad cholesterol): Between 70mg/dL (1.8 mmol/L) and < 190 mg/dL (4.9 mmol/L).
- Fasting triglycerides: < 400 mg/dL (< 4.52 mmol/L).
- Are receiving moderate or high-intensity statin therapy as per ACC/AHA (at least 2 months prior to screening).
- Body mass index (BMI): ≥ 19.0 kg/m2.
- Are capable of providing signed informed consent and comply with study requirements.
Contact us for more information: 786-772-0510
Active-controlled study to assess the efficacy, safety, and tolerability of investigational drug Baxdrostat in combination with Dapagliflozin compared with Dapagliflozin alone on chronic kidney disease (CKD) progression in participants with CKD and high blood pressure.
Study to Evaluate the Efficacy, Safety and Tolerability of Balcinrenone in Combination with Dapagliflozin Compared with Dapagliflozin in Patients with Chronic Kidney Disease and Albuminuria.
We are looking for subjects who are affected by uncontrolled hypertension to participate in a research study to investigate a new experimental treatment.
Your participation in the study will help to determine whether an investigational vaccine helps to provide protection against RSV in different populations.
The VICTORION-2 PREVENT Study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD).
Learn more about a clinical trial of a study drug for people who are living with HFrEF. Also called systolic heart failure, HFrEF is a type of cardiac dysfunction where the heart is too weak to pump enough blood around the body.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)